Demand for Veterinary Artificial Insemination Market to Incur Considerable Upsurge During 2021– 2028: Grand View Research Inc.

 

Veterinary Artificial Insemination Market Growth & Trends

The global veterinary artificial insemination market size is expected to reach USD 6.24 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.94% from 2021 to 2028. The market for veterinary artificial insemination is anticipated to witness a rise in demand owing to increasing consumption of animal protein and growing demand for high cattle productivity and milk yield. To fulfill the continuously increasing demand, market players are adopting artificial insemination to breed high-quality livestock and enhance production. For example, in August 2020, Cogent with AB Europe has launched a novel sexed semen service for sheep producers in the U.K. The demand has increased over the years owing to the rising prevalence of various animal diseases, such as zoonotic diseases, and the growing adoption of companion animals.

According to the Food and Agriculture Organization (FAO) publication 2019, livestock contributed almost 40% of the global value of agricultural output in developed countries and 20% in the developing ones, and it provides food security and livelihood to more than 1.3 billion people worldwide. Favorable government regulations intended to improve productivity are also leading to growth. For instance, the Indian government approved an Agriculture Export Policy in 2018 to enhance agricultural economic growth in the nation. The new policy is aimed at boosting India's agricultural output to USD 60 billion by 2022 and USD 100 billion with a predictable foreign policy framework in the next few years.

The market follows the standards set by the International Society of Artificial Insemination (ISAG) and leading animal research laboratories, such as The University of California Davis (U.C. Davis). The ISAG standard panel consists of 18 STR markers and any company in artificial insemination needs to follow the panel and standard set by the authority. However, the increasing population is expected to pose a continuous challenge to food availability and animal protein requirement, aiding the growth of the market.

Request a free sample copy or view report summary: Veterinary Artificial Insemination Market Report

Veterinary Artificial Insemination Market Report Highlights

• On the basis of animal type, the cattle segment was the largest revenue-generating segment in 2020 owing to the increasing consumption of milk and its products in Asian countries
• Based on product, the normal semen segment accounted for the largest revenue share in 2020 owing to the low cost of the procedure
• The sexed semen product segment is expected to witness the fastest growth during the forecast period. In 2016, ST Genetics produced 4 million X chromosome into an AI straw. The company sells sexed semen for five species of animals, including cattle, deer, sheep, horses, and goats. The rate of semen straws ranges between USD 65 and USD 250 for apiece as of 2018, depending on the quality, species, and use of the animal
• By end use, the animal husbandry segment accounted for the largest share in 2020 and is expected to maintain its lead throughout the forecast period. The growth can be attributed to a maximum number of semen collection procedures performed under these facilities
• The Asia Pacific accounted for the largest revenue share in 2020 mainly due to the large cattle population in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-veterinary-artificial-insemination-market

Veterinary Artificial Insemination Market Segmentation

Grand View Research has segmented the global veterinary artificial insemination market on the basis of animal type, product, end use, and region:

Veterinary Artificial Insemination Animal Type Outlook (Revenue, USD Million, 2016 - 2028)

• Cattle
• Swine
• Sheep
• Canine
• Equine
• Others

Veterinary Artificial Insemination Product Outlook (Revenue, USD Million, 2016 - 2028)

• Normal Semen
• Sexed Semen

Veterinary Artificial Insemination End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Veterinary Hospitals
• Animal Husbandry
• Others

Veterinary Artificial Insemination Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Veterinary Artificial Insemination Market

• Swine Genetics International
• Select Sires, Inc.
• SEMEX
• Cooperative Resource International (GENEX)
• Zoetis
• Cogent
• Genus plc
• Viking Genetics
• Polar Genetics India Private Limited
• Fox Fire Farm
• Xcell Breeding & Livestock Services Private Limited

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Foods Market To Hold a High Potential for Growth by 2028

 Medical Foods Market Growth & Trends

The global medical foods market size is anticipated to reach USD 30.34 billion by 2028 according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% over the forecast period. Factors such as the growing prevalence of chronic conditions along with the increasing geriatric population adopting medical foods are positively impacting the growth. Rising awareness regarding clinical nutrition among healthcare professionals and patients is projected to further bolster the growth over the forecast period.

Based on the route of administration, oral administration dominated the market in 2020. Factors contributing to the high share include high commercial viability of orally administered products and high preference for orally administered medical foods owing to ease in consumption. Oral supplements are available in various forms such as powders, pills, puddings, and pre-thickened products, thereby propelling the overall growth.

In 2020, based on product type, the others segment accounted for the highest revenue share. The others' segment comprises of liquid, semi-liquid, and semi-solid products. This growth is attributed to increasing application areas of medical foods, high commercial availability, and easy administration of these products. Owing to ease of consumption, liquid formulations are preferred by geriatric as well as pediatric populations, thereby increasing its overall revenue share.

Based on application, diabetic neuropathy dominated the market share in 2020. Rising diabetes prevalence and an increase in the number of patients that are at risk of developing some level of neuropathy are some of the factors boosting the overall growth. For instance, according to Healthline, around 60% to 70% of people suffering from diabetes have some or other form of neuropathy. The risk of suffering from neuropathy increases with an aging, unhealthy lifestyle, and change in diet which leads to an increased focus on nutritional management, thereby fueling the growth.

In 2020, based on sales channels, institutional sales accounted for the highest revenue share. This share is attributable to higher adoption and consumption of enteral and oral medical foods in healthcare institutions such as hospitals, clinics, and care centers. There is an increase in demand for such products in inpatient facilities. Hence, rising demand and consumption of these products under medical supervision are some of the factors contributing to the growth of the segment.

North America dominated the market with a revenue share of 29.9% in 2020 owing to the presence of key market players and high revenue generated by these players in this region. Strategic initiatives by players, increasing prevalence of chronic conditions, and rising adoption of medical foods by healthcare professionals and patients are other factors supporting the regional market growth.

Request a free sample copy or view report summary: Medical Foods Market Report

Medical Foods Market Report Highlights

• The oral segment accounted for the highest revenue share in 2020, owing to the high commercial viability of orally administered products and high preference for orally administered medical foods
• The others' segment dominated the market in 2020, owing to increasing application areas, high commercial availability, and easy administration of the products
• Diabetic Neuropathy dominated the market in 2020, owing to increasing diabetes prevalence and the rising number of patients that are at risk of developing some level of neuropathy
• Institutional sales accounted for the highest revenue share in 2020, owing to higher adoption and consumption of enteral and oral medical foods in healthcare institutions such as hospitals, clinics, and care centers
• North America dominated the market with a revenue share of 29.9% in 2020, owing to the presence of key market players and high revenue generated by these players in this region

Access Press Release of Medical Foods Market @ https://www.grandviewresearch.com/press-release/global-medical-foods-market

Medical Foods Market Segmentation

Grand View Research has segmented the global medical foods market based on the route of administration, product, application, sales channel, and region:

Medical Foods Route of Administration Outlook (Revenue, USD Million, 2014 - 2028)

• Oral
• Enteral

Medical Foods Product Outlook (Revenue, USD Million, 2014 - 2028)

• Pills
• Powder
• Others

Medical Foods Application Outlook (Revenue, USD Million, 2014 - 2028)

• Chronic Kidney Disease
• Minimal Hepatic Encephalopathy
• Chemotherapy-induced Diarrhea
• Pathogen Related Infections
• Diabetic Neuropathy
• ADHD
• Depression
• Alzheimer's Disease
• Nutritional Deficiency
• Orphan Diseases
  • Phenylketonuria
  • Eosinophilic Esophagitis
  • FPIES
  • Others
• Other 

Medical Foods Sales Channel Outlook (Revenue, USD Million, 2014 - 2028)

• Online Sales
• Retail Sales
• Institutional Sales

Medical Foods Regional Outlook (Revenue, USD Million, 2014 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
• Asia-Pacific
  • Australia
  • China
  • Japan
  • South Korea
  • India
  • New Zealand
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Medical Foods Market

• Danone
• Nestle Nutrition
• Abbott Nutrition
• Targeted Medical Pharma, Inc.
• Primus Pharmaceuticals, Inc.
• Mead Johnson & Company, LLC.
• Medtrition, Inc.
• Fresenius Kabi AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Impact of Existing and Emerging Platelet Rich Plasma Market Trends And Forecast 2021-2028

 Platelet Rich Plasma Market Growth & Trends

The global platelet rich plasma market size is estimated to reach USD 1.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.0% from 2021 to 2028. Several research studies have been performed recently to assess the conditions and incidences of platelet rich plasma (PRP) usage across both nonoperative as well as operative settings. Recent research on these lines has concluded that the breadth and use of platelet rich plasma have increased significantly among Medicare beneficiaries, which is expected to drive the market.

Technological advancements in the development of novel and innovative platelet rich plasma products are expected to propel market growth. Market participants are developing advanced products to reinforce their market share and overcome current limitations. In February 2020, Florida-based EmCyte Corporation received FDA’s 510(k) approval for its PurePRP Supraphysiologic Concentrating System, intended for producing platelet rich plasma from a small quantity of blood sample at Point-of-care (PoC) settings. This is an advanced autologous biologic concentrating system that can enable clinicians to improve their work.

The potential value of the market products lies in its ability to include high concentrations of platelet-derived fibrin and growth factors. Several research studies have demonstrated beneficial results with the usage of PRP in a wide range of clinical applications, such as orthopedics, sports medicine, cosmetic surgery, general surgery, neurosurgery, ophthalmic surgery, and others.

PRP injections are widely accepted in the orthopedic treatment, particularly focused towards joint pain relief and other bone defects, propelling the industry growth. It is also used to stimulate the formation of bone in spinal fusion surgeries. Additionally, integration of PRP in the management of COVID-19 patients, as an adjunct therapy is further expected to offer profitable business opportunities for the entities operational in this market.

Request a free sample copy or view report summary: Platelet Rich Plasma Market Report

Platelet Rich Plasma Market Report Highlights

• The pure PRP segment accounted for the largest revenue share of over 52.0% in 2020. Compared to Leukocyte Rich Platelet rich plasma (LR-PRP), pure PRP can promote better repair of bone defects
• LR-PRP can enhance bone regeneration by improving viability, proliferation, migration of cells in vitro, and osteogenesis and angiogenesis in vitro and in vivo
• However, LR-PRP products can produce adverse or inferior effects, making pure type more suitable for bone regeneration
• The combined use of P-PRP with β-tricalcium phosphate (β-TCP) is considered a simple, safe, and effective option in the treatment of bone defects. These factors are expected to boost the utilization of the same
• Orthopedics dominated the market in 2020 accounting for a market share of more than 29.0%, while dermatology is expected to witness the fastest growth rate over the forecast period
• A large number of orthopedic and general surgeries being performed in hospitals is contributing to the dominant share held by hospitals in the market
• The growing competition in the global market can be attributed to the presence of several well-established companies as well as small and midsized entities
• Established manufacturers are observing strategic product developments to ensure maximum product reach
• In October 2019, a new design for packaging was introduced by Croma-Pharma GmbH for the company’s ACP double syringe system. The unique appearance of Croma products has been integrated in this new design. Croma is an exclusive distributor of the Arthrex ACP double syringe system in 9 countries in Europe

Access Press Release of Platelet Rich Plasma Market @ https://www.grandviewresearch.com/press-release/global-platelet-rich-plasma-prp-market

Platelet Rich Plasma Market Segmentation

Grand View Research has segmented the global platelet rich plasma market on the basis of type, application, end-use, and region:

PRP Type Outlook (Revenue, USD Million, 2017 - 2028)

• Pure Platelet Rich Plasma
• Leukocyte Rich Platelet Rich Plasma
• Others

PRP Application Outlook (Revenue, USD Million, 2017 - 2028)

• Orthopedics
• Sports Medicine
• Cosmetic Surgery
• Dermatology
  • Ulcer Healing
    • Venous Ulcer
    • Traumatic Ulcer
    • Diabetic Ulcer
    • Pyoderma Gangrenosum Ulcer
    • Trophic Ulcer
    • Vasculitic Ulcer
    • Others
  • Others
• Ophthalmic Surgery
• Neurosurgery
• General Surgery
• Others

PRP End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Hospitals
• Clinics
• Others

PRP Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

List of Key Players of Platelet Rich Plasma (PRP) Market

• Johnson & Johnson (DePuy Synthes)
• Zimmer Biomet
• Stryker
• EmCyte Corporation
• Terumo BCT, Inc.;
• Arthrex, Inc.
• PRP America
• Juventix
• APEX Biologix
• Celling BioSciences

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Thermometer Market To Benefit from Increased Global Uptake of 2021 By 2028

 Thermometer Market Growth & Trends

The global thermometer market size is expected to reach USD 2.34 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% from 2021 to 2028. An increase in the demand for accurate medical devices and the requirement of specific temperature conditions influence the market growth.

The rising cases of medical ailments involving accurate measurement of body temperature for the treatment planning and requirement of specific temperature conditions in various industries are likely to heighten the demand for thermometers during the forecast period. The rise in health consciousness, coupled with an increase in healthcare expenditure, is also anticipated to fuel market growth further in the coming decade.

The increasing prevalence of target diseases, such as malaria, dengue, typhoid, and swine flu, which cause fever, is anticipated to be a high-impact rendering driver of the market. Malaria is one of the most fatal diseases and is one of the leading causes of death globally. According to the World Malaria Report 2019, an estimated 229 million cases of malaria were observed in 2019 globally.

Furthermore, rapid technological advancements in temperature monitoring devices are increasing the acceptance of these devices by people. For instance, in 2018, Optics developed upgrades for its compact infrared thermometers, which improved their speed and flexibility for industrial use. This is expected to boost the market growth during the forecast period.

Request a free sample copy or view report summary: Thermometer Market Report

Thermometer Market Report Highlights

• Based on product, mercury-free thermometers dominated the market with a share of 62.52% in 2020 and are expected to witness significant growth from 2021 to 2028. This can be attributed to the high adoption owing to cost-effectiveness, higher efficacy, and beep indication on temperature fluctuations
• On the basis of application, the medical segment dominated the market with a share of 28.53% in 2020 owing to the high prevalence of diseases, which require body temperature assessment for the treatment planning
• North America dominated the market with a revenue share of 34.45% in 2020 owing to the increasing incidences of infectious diseases, such as COVID-19 and Influenza, and the presence of well-established healthcare facilities in this region

Access Press Release of Thermometer Market @ https://www.grandviewresearch.com/press-release/global-thermometer-market

Thermometer Market Segmentation

Grand View Research has segmented the global thermometer market on the basis of product, application, and region:

Thermometer Product Outlook (Revenue, USD Million, 2016 - 2028)

• Mercury-based Thermometers
• Mercury-free Thermometers
  • Infrared Radiation Thermometers
  • Digital Thermometers
  • Others

Thermometer Application Outlook (Revenue, USD Million, 2016 - 2028)

• Medical
• Industrial
• Food
• Laboratory
• Others

Thermometer Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
• Middle East and Africa (MEA)
  • South Africa

List of Key Players of Thermometer Market

• Medline Industries, Inc.
• 3M
• Welch Allyn
• American Diagnostics Corporation
• A&D Medical
• Exergen Corporation
• Microlife Corporation
• RG Medical Diagnostics
• Medtronic
• Terumo Corporation
• Actherm Inc.
• Briggs Healthcare
• OMRON Healthcare Inc.
• Fairhaven Health

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Gene Therapy Market is projected to grow moderately at 20.4% CAGR through 2028: Grand View Research Inc.

 

Gene Therapy Market Growth & Trends

The global gene therapy market size is expected to reach USD 10.0 billion by 2028 registering a CAGR of 20.4% during the forecast period, according to a new report by Grand View Research, Inc. The market growth is attributed to the increasing prevalence of cancer coupled with the lack of effective treatment for the disease. Constant expansion of cancer genetic studies has deciphered relevant information about cancer-related molecular signatures.

This has driven the clinical trials for advanced cancer therapeutics, thereby driving the market growth. In addition, expansion of this mode of treatment in non-cancer applications with approval of therapies, such as approval of Bluebird Bio’s Zynteglo in June 2019 for β-thalassemia and others, demonstrates the shift in the preferences of companies towards other unsaturated segments.

Various universities and institutes are observed to exhibit a broad portfolio in the pipeline, which is anticipated to boost revenue generation in the future. The market is anticipated to witnesses a short-term revenue slowdown due to a shift in focus and delay in product launches. However, initiatives for developing novel trial designs, improving the regulatory environment, and managing the supply chain are expected to play a critical role in minimizing the impact of the current global crisis.

Request a free sample copy or view report summary: Gene Therapy Market Report

Gene Therapy Market Report Highlights

• Viral vectors have proven their efficiency as a method for effective gene deliveries. As a result, a substantial number of research communities and biotechnology companies have designed their gene therapy programs based on viral vectors
• Moreover, most of currently FDA-secured products involve the use of viral vectors, which contributes to the dominance of the viral vectors segment
• Due to the approval and huge success of lentivirus-based Kymriah and retrovirus-based Yescarta, retrovirus and lentivirus are also among the key revenue-generating segments
• Cancer has led the revenue flow in the market over the past few years and is expected to maintain its dominance in the forecast period
• The presence of approved products for various cancer forms including Large B-cell lymphoma, Acute Lymphoblastic Leukemia (ALL), and melanoma has resulted in the dominance of this segment
• The U.S. is recognized as the hub for clinical trials related to gene therapy. This has significantly impacted the revenue growth of the North America market
• Also, the success of Yescarta and Kymriah in the U.S. as the first approved CAR-t therapy programs has driven huge investments by various government agencies, sponsors, and key companies in this region
• Major market participants are partnering with other key stakeholders via signing licensing, commercialization, and development deals to enhance their worldwide business operations
• For instance, in June 2020, uniQure announced a license agreement with CSL Behring for the commercialization of hemophilia B gene therapy

Access Press Release of Gene Therapy Market @ https://www.grandviewresearch.com/press-release/global-gene-therapy-market

Gene Therapy Market Segmentation

Grand View Research has segmented the global gene therapy market on the basis of indication, vector type, and region:

Gene Therapy Indication Outlook (Revenue, USD Million, 2017-2028)

• Acute Lymphoblastic Leukemia (ALL)
• Inherited Retinal Disease
• Large B-cell Lymphoma
• ADA-SCID
• Melanoma (lesions)
• Beta-Thalassemia Major/SCD
• Head & Neck Squamous Cell Carcinoma
• Peripheral Arterial Disease
• Spinal Muscular Atrophy (SMA)
• Others

Gene Therapy Vector Type Outlook (Revenue, USD Million, 2017-2028)

• Lentivirus
• AAV
• Retrovirus & gamma Retrovirus
• Modified Herpes Simplex Virus
• Adenovirus
• Non-viral Plasmid Vector

Gene Therapy Regional Outlook (Revenue, USD Million, 2017-2028)

• North America
  • US.
  • Canada
• Europe
• Asia Pacific
  • Japan
  • China
  • Russia
• Australia
• Rest of the World

List of Key Players of Gene Therapy Market

• REGENXBIO, Inc.
• Oxford BioMedica plc
• Dimension Therapeutics, Inc.
• Bristol-Myers Squibb Company
• SANOFI
• Applied Genetic Technologies Corporation
• Hoffmann-La Roche Ltd.
• Bluebird Bio, Inc.
• Novartis AG
• Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
• UniQure N.V.
• Shire Plc
• Cellectis S.A.
• Sangamo Therapeutics, Inc.
• Orchard Therapeutics
• Gilead Lifesciences, Inc.
• Benitec Biopharma Ltd.
• Sibiono GeneTech Co., Ltd.
• Shanghai Sunway Biotech Co., Ltd.
• Gensight Biologics S.A.
• Transgene
• Calimmune, Inc.
• Epeius Biotechnologies Corp.
• Astellas Pharma, Inc.
• American Gene Technologies
• BioMarin Pharmaceuticals, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wearable Injectors Market Projected to Discern Stable Expansion by 2028

 Wearable Injectors Market Growth & Trends

The global wearable injectors market size is expected to reach USD 18.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 17.2% from 2021 to 2028. Wearable injectors are drug administration devices designed to deliver drugs in large volumes subcutaneously. It is gaining popularity owing to its advantages such as reduced pain, ease of administration, and elimination of costly health facility visits.

Over the last decade, patient interest in the self-administration of injectable drug therapies has grown. The increasing prevalence of diabetes, chronic pain, and auto-immune diseases, such as rheumatoid arthritis, is increasing the use of wearable injectors. Their demand is increasing for the long-term management of asthma, chronic obstructive pulmonary disease (COPD), high cholesterol, and cancer. This is expected to create a lucrative opportunity for advanced device manufacturers to make wearable devices used to administer larger dose volumes at the comfort of home.

The recent COVID-19 pandemic has brought remote care technologies, such as wearable injectors, into the spotlight. Demand for chronic disease products remains largely unaffected by the pandemic. Since wearable injectors serve with the option of delivering medications at home, its demand has also remained stable or rather grown for the short term. Patients suffering from chronic diseases are opting for these devices as it reduces the risk of exposure to COVID-19 by eliminating hospital visits. The pandemic has, however, affected some of the devices in the pipeline, affecting short-term investments. Leading players who continue to invest in innovation push projects forward despite COVID-19 are expected to put their companies in a stronger competitive position post-crisis.

Request a free sample copy or view report summary: Wearable Injectors Market Report

Wearable Injectors Market Report Highlights

• By type, the on-body segment led the market in 2020 owing to its advantage to be worn on the skin
• The spring-based technology segment held the largest share of 36.3% in 2020 due to a rise in demand for adhesive patches for the treatment of chronic conditions, such as cancer and diabetes
• The home care end-use segment led the market in 2020. This can be attributed to a rise in preference for self-administration, especially during the COVID-19 pandemic
• North America dominated the market with a share of 41.5% in 2020 owing to the rising prevalence of chronic diseases

Access Press Release of Wearable Injectors Market @ https://www.grandviewresearch.com/press-release/global-wearable-injectors-market

Wearable Injectors Market Segmentation

Grand View Research has segmented the global wearable injectors market based on type, technology, application, end-use, and region:

Wearable Injectors Type Outlook (Revenue, USD Million, 2016 - 2028)

• On-body
• Off-body

Wearable Injectors Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Spring-based
• Motor-driven
• Rotary Pump
• Expanding Battery
• Others

Wearable Injectors Application Outlook (Revenue, USD Million, 2016 - 2028)

• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Autoimmune Diseases
• Others

Wearable Injectors End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinics
• Home Care
• Others

Wearable Injectors Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Wearable Injectors Market

• Becton, Dickinson and Company
• Johnson & Johnson Services, Inc.
• Hoffmann-La Roche Ltd.
• Unilife Corporation
• SteadyMed Therapeutics, Inc.
• Amgen, Inc.
• Insulet Corporation
• Enable Injections
• West Pharmaceutical Services, Inc.
• CeQur SA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Drug Of Abuse Testing Services Market Key Players ,Industry Share ,Growth, And Forecast To 2028: Grand View Research Inc.

 Drug Of Abuse Testing Services Market Growth & Trends

The global drug of abuse testing services market size is expected to reach USD 3.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2021 to 2028. The imposition of stringent laws mandating alcohol and illicit substance abuse testing is anticipated to drive the market during the forecast period. However, the violation of privacy rights while drug testing is considered a challenge and impedes the adoption of such testing services.

Workplace substance abuse is on the rise despite random tests being conducted by organizations. Commonly abused illicit drugs on the job are cannabis and cocaine. In the workplace, substance abuse might lead to significant loss of productivity, physical injuries, and even fatalities. On the basis of various drug abuse surveys, around 22.5% of people do not admit using alcohol or any illicit drugs during working hours. Around 1 in 10 respondents say that they come prepared to avoid the risk of random tests at the workplace. Therefore, there is a growing need for rapid and frequent drug of abuse testing at the workplace in order to minimize loss of productivity, absenteeism, and healthcare costs. However, with the COVID-19 crisis and subsequent lockdown scenarios throughout the world, people are staying at and working from home, which is expected to reduce the number of substance abuse cases at the workplace.

The National Institute on Drug Abuse (NIDA) has been established as one of the major federal agencies focused on supporting scientific research on drug use disorders and their consequences, thus improving public health. In March 2020, the NIDA issued a Notice of Special Interest (NOSI) highlighting the urgent need for research and data collection and analysis on the risks of COVID-19 infection in people suffering from substance use disorders. This pandemic is a potential threat to individuals who smoke tobacco or marijuana or try vaping, as the infection affects the lungs. This initiative aims at the submission of applications for Competitive Revisions to active grants, targeting research about SARS-CoV-2 infection risks in individuals with substance use disorders, especially with marijuana, nicotine, methamphetamine, and opioids.

Request a free sample copy or view report summary: Drug Of Abuse Testing Services Market Report

Drug Of Abuse Testing Services Market Report Highlights

• By drug type, cannabis/marijuana accounted for the largest market share in 2020. This can be attributed to the growing usage of cannabis across the world, especially in the U.S.
• The opioids drug type segment held a significant revenue share in 2020 due to the growing cultivation and trading of opioids in Asian countries and a rise in related overdose deaths
• North America accounted for the largest market share in 2020 due to the highest consumption of illicit drugs in the U.S. as well as the imposition of various drug policies mandating drug screening in the country
• Latin America is anticipated to witness the fastest growth during the forecast period owing to the increasing usage and trading of illegal drugs
• COVID-19 has led to a significant rise in alcohol and other substance abuse globally; however, demand for drug testing has declined due to the increased focus on measures to combat the pandemic

Access Press Release of Drug Of Abuse Testing Services Market @ https://www.grandviewresearch.com/press-release/global-drugs-abuse-testing-services-market

Drug Of Abuse Testing Services Market Segmentation

Grand View Research has segmented the global drug of abuse testing services market on the basis of drug type and region:

Drug Of Abuse Testing Services Drug Type Outlook (Revenue, USD Million, 2016 - 2028)

• Alcohol
• Cannabis/Marijuana
• Cocaine
• Opioids
• Amphetamine & Methamphetamine
• LSD
• Others

Drug Of Abuse Testing Services Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
  • Chile
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Drug Of Abuse Testing Services Market

• Quest Diagnostics
• Abbott Laboratories
• Clinical Reference Laboratory (CRL), Inc.
• Laboratory Corporation of America Holdings
• Cordant Health Solutions
• Legacy Medical Services
• DrugScan
• Omega Laboratories, Inc.
• Psychemedics Corporation
• Millennium Health
• Mayo Clinic Laboratories
• Precision Diagnostics
• American Substance Abuse Professionals, (ASAP) Inc.
• United States Drug Testing Laboratories (USDTL), Inc.
• LGC Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Burn Care Market Soaring Demand Assures Motivated Revenue Share By 2028

Burn Care Market Growth & Trends

The global burn care market size is expected to reach USD 3.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.9% from 2021 to 2028. Increasing incidences of burn injuries are anticipated to fuel the demand for cost-effective treatment over the forecast period. As per the WHO, 96.0% of fatal fire-related burns occur in low to middle-income countries. According to the data published by WHO, on average 265,000 deaths are caused by burns every year. The majority of these deaths occur in low to middle-income countries and half of them occur in South East Asia. Moreover, around 1,000,000 people in India are moderately or severely burnt and around 173,000 children in Bangladesh are burnt each year. It also reported that in the U.S., approximately 4,500 burn victims die annually and 10,000 die due to burn-related infections. Owing to this substantial increase in the number of burn incidences, the patient population for burn care and treatment has increased. This in turn is expected to drive market growth over the forecast period.

Furthermore, due to the rising incidences of burn, the demand for treatment options is increasing and as a result, the overall healthcare expenditure on burn care is increasing. Treatment options for burn care include advanced dressings, biologics, traditional burn care products, and others. The foam dressings developed from semipermeable polyurethane are waterproof and can be used on heavily exuding wounds. As a result of which they are preferred over normal dressings which are not waterproof and need to be changed regularly.

Request a free sample copy or view report summary: Burn Care Market Report

Burn Care Market Report Highlights

• The moist wound dressing segment dominated the market in 2020 due to the rising technological advancements and increasing demand for advanced treatment options
• On the basis of depth of wound, the partial thickness burn segment is anticipated to witness the fastest growth over the forecast period. The growth of the segment is attributable to the favorable reimbursement policies in the developed countries
• The hospitals segment accounted for the largest share of the market owing to the increasing incidence of burn injuries and hospitalizations each year
• The thermal burns segment held the largest share of the market in 2020 owing to a high incidence of fire-related burn injuries

Access Press Release of Burn Care Market @ https://www.grandviewresearch.com/press-release/global-burn-care-market

Burn Care Market Segmentation

Grand View Research has segmented the burn care market on the basis of the product, depth of wound, cause, end-use, and region:

Burn Care Product Outlook (Revenue, USD Million, 2016 - 2028)

• Advanced Dressing
  • Alginate Dressing
  • Collagen Dressing
  • Hydrogel Dressing
  • Hydrocolloid Dressings
  • Wound Contact Layers
  • Film Dressings
  • Foam Dressings
  • Others
• Biologics
• Traditional Burn Care Products
• Others

Burn Care Depth of Wound Outlook (Revenue, USD Million, 2016 - 2028)

• Minor Burns
• Partial Thickness Burns
• Full Thickness Burns

Burn Care Cause Outlook (Revenue, USD Million, 2016 - 2028)

• Thermal Burns
• Electrical Burns
• Radiation Burns
• Chemical Burns
• Friction Burns

Burn Care End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinics
• Others

Burn Care Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Burn Care Market

• 3M
• Hollister Incorporated
• Cardinal Health
• Integra LifeSciences Corporation
• KCI Licensing, Inc. (Acelity L.P. Inc.)
• Coloplast Corp.
• DeRoyal Industries, Inc.
• Smith & Nephew
• ConvaTec Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Vertical Farming Market is Estimated To Reach A Valuation of $21.15 Billion by 2028: Grand View Research Inc.

 Vertical Farming Market Growth & Trends

The global vertical farming market size is anticipated to reach USD 21.15 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 23.6% over the forecast period. Increased use of Internet of Things (IoT) sensors for producing crops is likely to spur the market demand over the forecast period. Information obtained from the sensors is stored on the cloud and analyzed to perform the required actions. Growing automation in agriculture and increasing use of big data and predictive analytics for maximizing yields are also likely to drive the market.

Vertical farming is effective in ensuring stability in crop production and maintaining reliability even in adverse climatic conditions. It provides multiple benefits over traditional farming techniques, such as less use of water, the lesser need for agrochemicals, and low dependence on agricultural labors. Vertical farming makes use of metal reflectors and artificial lighting to maximize natural sunlight.

Genetically modified organisms and environmental and health effects of pesticides and other non-natural substances that are used for increasing agricultural production have encouraged consumers to adopt organic foods. According to the Organic Trade Association, the U.S. organic industry sales increased by around 5% in 2019, owing to increased investment in infrastructure and education. As per the Organic Foods Production Act of 1990, the handlers and growers of organic products need to comply with the regulations.

Artificial lighting helps in extending the hours of natural daylight, which further increases the health, growth rate, and yield of the plants. Artificial lighting such as high-pressure sodium lighting and LED lighting can extend the availability of crops (throughout a season). LED lighting systems produce a dual-band color spectrum and generate low heat. They are anticipated to witness significant growth over the forecast period.

The hydroponic system is a method of growing plants without soil. A hydroponic system eliminates the need for pesticides and artificial ripening agents and helps in producing nutritionally-rich vegetables. However, factors such as high initial investment and fewer crop varieties are likely to restrain the market growth.

Request a free sample copy or view report summary: Vertical Farming Market Report

Vertical Farming Market Report Highlights

• The escalating production of biopharmaceutical products is anticipated to drive the market
• The building-based segment is expected to portray a high CAGR of 25.9% over the projected period
• The climate control segment is expected to witness a high CAGR over the forecast period, as the growth of crops can be controlled by monitoring and adjusting the concentrations of minerals
• The aeroponics segment is also expected to register considerable growth over the forecast period, as the aeroponics facilitates fast growth in plants (under normal conditions)
• North America is expected to register significant growth over the forecast period, owing to the expansion of small-scale, commercial vertical farms
• The key players of the market include BrightFarms (U.S.), Everlight Electronics Co., Ltd. (Taiwan), and Green Sense Farms, LLC (U.S.)

Vertical Farming Market Segmentation

Grand View Research has segmented the global vertical farming market based on structure; offering; growing mechanism; fruits, vegetables, & herbs; and region:

Vertical Farming Structure Outlook (Revenue, USD Million, 2017 - 2028)

• Shipping Container
• Building-based

Vertical Farming Offering Outlook (Revenue, USD Million, 2017 - 2028)

• Lighting
• Hydroponic Components
• Climate Control
• Sensors

Vertical Farming Growing Mechanism Outlook (Revenue, USD Million, 2017 - 2028)

• Hydroponics
• Aeroponics
• Aquaponics

Vertical Farming Fruits, Vegetables, & Herbs Outlook (Revenue, USD Million, 2017 - 2028)

• Tomato
• Lettuce
• Bell & Chili Peppers
• Strawberry
• Cucumber
• Leafy Greens
• Herbs
• Others

Vertical Farming Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Singapore
  • South Korea
• South America
  • Brazil
• Middle East and Africa (MEA)

List of Key Players in Vertical Farming Market

• AeroFarms
• Freight Farms
• Green Sense Farms, LLC
• BrightFarms Inc.
• Everlight Electronics Co., Ltd.
• Agrilution Systems GmbH

Access Press Release of Vertical Farming Market @ https://www.grandviewresearch.com/press-release/global-vertical-farming-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Corporate Wellness Market Overview and Rising Dependency on Factors 2021 – 2028: Grand View Research Inc.

 

Corporate Wellness Market Growth & Trends

The global corporate wellness market size is expected to reach USD 93.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.0% from 2021 to 2028. Rising obese and overweight population increases insurance costs that account for the financial burden on the employers. The corporate wellness initiatives target particular health risk factors such as stress, obesity, smoking, poor eating, and lack of exercise.

The pandemic has caused a change in the process of delivering wellness services. Although in-person sessions have resumed to some extent, the virtual platform has been made available to at-risk employees to meet their psychological and fitness needs. Initially, the lockdown imposed due to COVID19 resulted in transition to work from home, causing a great deal of stress. 

Employers have started offering some kind of fitness program for the purpose of disease prevention and improve productivity. According to a study conducted by Harvard economists, absenteeism costs fall by USD 2.7 for every dollar spent on fitness programs. Therefore, employees need to be encouraged to adopt a healthier lifestyle to improve their performance.

Employers providing the programs have noticed a significant rise in productivity and a decline in leaves and attrition. In addition, companies in the U.K. initiated the Fit for Work service, which offers a tax benefit of USD 663.3 per year. Organizations are providing wearables, such as Fitbit, Apple watch, and Google watches, which helps in keeping track of parameters such as heart rate and blood pressure.

Access Research Report of Corporate Wellness Market@ https://www.grandviewresearch.com/industry-analysis/corporate-wellness-market

Corporate Wellness Market Report Highlights

• The health risk assessment segment dominated the overall market in terms of revenue share in the year 2020. The health screening activities enable employers to implement strategic initiatives to deal with the identified health risks
• The stress management segment is likely to showcase the fastest growth rate from 2021 to 2028, owing to the rising preference for on-site yoga and meditation services
• Large scale organizations dominated the end use segment in the market in 2020. The infrastructure in large scale companies makes conducting fitness services easier and convenient
• North America dominated the market in terms of revenue share in 2020 due to popularity of corporate wellness in the region. According to a survey by Benefits Canada conducted on 1300 employers, North America had the highest number of corporate wellness programs. In this region, more than 80.0% of the employers are offering corporate wellness services to their employees
• Companies around the globe are modifying their corporate wellness strategies to meet the emerging public health crisis due to COVID 19, though the effect has been surprisingly positive

Access Press Release of Corporate Wellness Market@ https://www.grandviewresearch.com/press-release/global-corporate-wellness-market

Corporate Wellness Market Segmentation

Grand View Research has segmented the global corporate wellness market on the basis of service, end-use, category, delivery model, and region:

Corporate Wellness Service Outlook (Revenue, USD Million, 2016 - 2028)

• Health Risk Assessment
• Fitness
• Smoking Cessation
• Health Screening
• Nutrition & Weight Management
• Stress Management
• Others

Corporate Wellness End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Small Scale Organizations
• Medium Scale Organizations
• Large Scale Organizations

Corporate Wellness Category Outlook (Revenue, USD Million, 2016 - 2028)

• Fitness & Nutrition Consultants
• Psychological Therapists
• Organizations/Employers

Corporate Wellness Delivery Model Outlook (Revenue, USD Million, 2016 - 2028)

• Onsite
• Offsite

Corporate Wellness Regional Outlook(Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • South Africa

List of Key Players of Corporate Wellness Market

• Medtronic (Covidien)
• ComPsych
• Wellness Corporate Solutions
• Virgin Pulse
• Provant Health Solutions
• EXOS
• Marino Wellness
• Privia Health
• Vitality Group
• Wellsource, Inc.
• Central Corporate Wellness
• Truworth Wellness
• SOL Wellness

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.